Nanoplasmonic Aptasensing Enables Real-Time Optical Monitoring of Neurotransmitters in Living Brainstem Organoids
ACS Nano · 2026
DOI: 10.1021/acsnano.6c09629 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Hanjun Cho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Institute of Quantum Biophysics, Sungkyunkwan University, Suwon16419, Republic of Korea. Hauptthemen laut MEDLINE: Organoids, Neurotransmitter Agents, Biosensing Techniques, Brain Stem. Die Arbeit nennt 89 Literaturangaben. Gefördert von: Korea Basic Science Institute, National Research Foundation of Korea.
Abstract (Originalsprache)
Disruption of dopamine signaling is central to Parkinson’s disease (PD) pathology and a primary target of symptomatic therapy. However, direct measurement of dopamine dynamics in human neural tissue with high sensitivity, temporal resolution, and compatibility with three-dimensional models remains technically challenging. Here, an organoid-on-a-chip platform that integrates a cavity-coupled nanoplasmonic aptasensor with human brainstem organoids (hBSOs) and microfluidic control is employed for label-free monitoring of the extracellular dopamine response. The plasmonic aptasensor achieves a limit of detection of 8.3 pM with minimal cross-reactivity with related catecholamines. Under static conditions, dopamine secretion from healthy- and PD-line hBSOs is quantified, revealing reduced basal secretion in PD-line organoids and selective enhancement by PD-targeted drugs compared with non-PD agents. Under perfused microfluidic conditions, L-DOPA-induced dopamine changes are monitored continuously over 12 h, and real-time spectral peak shifts are reconstructed into dopamine concentration–time profiles to assess kinetic responses to drug treatment. This real-time, nanoplasmonic neurotransmitter sensing framework links controlled drug dosing to extracellular dopamine dynamics in human neural organoid-on-chip systems for preclinical evaluation of PD therapies and other neuroactive perturbations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics, Institute of Quantum Biophysics, Sungkyunkwan University, Suwon16419, Republic of Korea.
- Department of Metabiohealth, Sungkyunkwan University, Suwon16419, Republic of Korea.
- Department of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon16419, Republic of Korea.
- Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon16419, Republic of Korea.
ORCID-Profile: Inki Kim
Förderung
- Korea Basic Science Institute
- National Research Foundation of Korea
Zitieren
APA
Cho, H., Kim, Y., Yoon, N., Hoang, T., Ahn, J., Kim, B., Bak, G., Lee, T., Yu, W. J., Park, J. C., & Kim, I. (2026). Nanoplasmonic Aptasensing Enables Real-Time Optical Monitoring of Neurotransmitters in Living Brainstem Organoids. ACS Nano. https://doi.org/10.1021/acsnano.6c09629
Vancouver
Cho H, Kim Y, Yoon N, Hoang T, Ahn J, Kim B, et al. Nanoplasmonic Aptasensing Enables Real-Time Optical Monitoring of Neurotransmitters in Living Brainstem Organoids. ACS Nano. 2026. doi:10.1021/acsnano.6c09629
BibTeX
@article{Cho2026,
author = {Cho, Hanjun and Kim, Youngjun and Yoon, Nahyun and Hoang, Trung and Ahn, Jungho and Kim, Beomsu and Bak, Gyusoo and Lee, Taehoon and Yu, Won Jong and Park, Jong-Chan and Kim, Inki},
title = {Nanoplasmonic Aptasensing Enables Real-Time Optical Monitoring of Neurotransmitters in Living Brainstem Organoids},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c09629}
}
EUVIMED